According to WebMD, Inluriyo (imlunestrant) is a new oral medication for certain cases of locally advanced or metastatic breast cancer that have progressed after at least one round of hormone therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback